Doctronic, a healthcare AI startup operating a controversial chatbot experiment for drug prescription renewals in Utah, has secured $40 million in new funding. The company represents part of the expanding race among startups to integrate artificial intelligence into clinical care settings.
The funding comes as healthcare organizations increasingly explore AI applications for routine medical tasks, with prescription management emerging as a key area of focus. Doctronic's Utah-based pilot program has drawn attention for its direct-to-patient approach using chatbot technology.